PMC:7290137 / 0-195 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":51,"end":62},"obj":"Body_part"},{"id":"T2","span":{"begin":63,"end":73},"obj":"Body_part"},{"id":"T3","span":{"begin":68,"end":73},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma55631"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma63368"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":51,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001754"}],"text":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":45,"end":50},"obj":"Species"},{"id":"4","span":{"begin":83,"end":91},"obj":"Species"},{"id":"5","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:9606"},{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"Tax:9606"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T2","span":{"begin":63,"end":73},"obj":"http://purl.obolibrary.org/obo/CL_0000034"},{"id":"T3","span":{"begin":136,"end":137},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":157,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I"}